Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Market Cap Dropped CN¥588m Last Week; Individual Investors Bore the Brunt
Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Market Cap Dropped CN¥588m Last Week; Individual Investors Bore the Brunt
Key Insights
主要见解
- Shinva Medical InstrumentLtd's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
- The top 14 shareholders own 50% of the company
- 23% of Shinva Medical InstrumentLtd is held by Institutions
- 新华医疗重要的个人投资者持股情况表明,关键决策受到较大公众股东的影响。
- 前14名股东持有该公司50%的股权。
- 新华医疗有23%的股份由机构持有。
Every investor in Shinva Medical Instrument Co.,Ltd. (SHSE:600587) should be aware of the most powerful shareholder groups. With 43% stake, individual investors possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
对于新华医疗股票(SHSE:600587)的每个投资者来说,都应该了解最大的股东群体。目前个人投资者持有43%的股份,这意味着如果股价上涨,该群体将获益最多(或者如果存在下跌,将亏损最多)。
As market cap fell to CN¥9.3b last week, individual investors would have faced the highest losses than any other shareholder groups of the company.
随着市值上周下降到93亿人民币,个人投资者将面临公司股东中最高的损失。
In the chart below, we zoom in on the different ownership groups of Shinva Medical InstrumentLtd.
在下面的图表中,我们将放大新华医疗的不同所有权集团。
What Does The Institutional Ownership Tell Us About Shinva Medical InstrumentLtd?
机构所有权告诉我们有关新华医疗的什么?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
许多机构衡量其业绩的标准是一个近似于当地市场的指数。因此,他们通常更加关注包括在主要指数中的公司。
As you can see, institutional investors have a fair amount of stake in Shinva Medical InstrumentLtd. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Shinva Medical InstrumentLtd's historic earnings and revenue below, but keep in mind there's always more to the story.
正如您所看到的,机构投资者在新华医疗有相当数量的股份。 这表明在专业投资者中有一定的信誉度。 但我们不能仅凭此事实,因为有时机构也会做出糟糕的投资,就像每个人一样。 当多家机构持有某支股票时,总会存在它们陷入"拥挤交易"状态的风险。 当这种交易出现问题时,多方可能竞相快速抛售股票。 在一家没有增长历史的公司中,这种风险会更高。 您可以在下方看到新华医疗的历史每股收益和营业收入,但请记住故事总是更为复杂的。
We note that hedge funds don't have a meaningful investment in Shinva Medical InstrumentLtd. Looking at our data, we can see that the largest shareholder is Shandong Energy Group Co., Ltd. with 29% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 4.1% and 3.9%, of the shares outstanding, respectively.
我们注意到对冲基金在新华医疗设备有着不多的投资。根据我们的数据,最大的股东是山东能源集团有限公司,持有29%的股份。同时,第二和第三大股东分别持有4.1%和3.9%的股份。
After doing some more digging, we found that the top 14 have the combined ownership of 50% in the company, suggesting that no single shareholder has significant control over the company.
经过更深入的挖掘,我们发现前14名股东合计持有该公司的50%股权,表明没有单一股东对该公司有重大控制权。
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There is some analyst coverage of the stock, but it could still become more well known, with time.
虽然研究公司的机构持股可以增加研究价值,但研究分析师建议以更深入地了解股票的预期表现也是一个好习惯。该股票的一些分析人士需要更多的关注时间。
Insider Ownership Of Shinva Medical InstrumentLtd
新华医疗设备有限公司的内部所有权
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
虽然内部人员的精确定义可能具有主观性,但几乎所有人都认为董事会成员是内部人员。管理层最终向董事会负责。然而,如果经理是创始人或CEO,那么他们成为执行董事会成员并不罕见。
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
我通常认为内部人士持股是一件好事。但是,在某些情况下,它会使其他股东更难以对董事会的决定进行问责。
Our information suggests that Shinva Medical Instrument Co.,Ltd. insiders own under 1% of the company. But they may have an indirect interest through a corporate structure that we haven't picked up on. Keep in mind that it's a big company, and the insiders own CN¥24m worth of shares. The absolute value might be more important than the proportional share. It is always good to see at least some insider ownership, but it might be worth checking if those insiders have been selling.
我们的信息显示,新华医疗器械股份有限公司的内部持股不到公司总股本的1%。但他们可能通过我们尚未发现的公司结构间接持有利益。请记住这是一家大公司,内部持股价值人民币2400万。绝对价值可能比持股比例更重要。至少看到一些内部持股总是不错的,但值得检查这些内部人员是否一直在抛售股份。
General Public Ownership
一般大众所有权
The general public, who are usually individual investors, hold a 43% stake in Shinva Medical InstrumentLtd. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
普通公众,通常是个人投资者,持有新华医疗仪器有限公司43%的股份。尽管这个群体不一定能决定事情的走向,但肯定会对公司的运营产生真正的影响。
Private Company Ownership
私有公司的所有权
Our data indicates that Private Companies hold 34%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
我们的数据表明,私营企业持有公司股份的34%。深入了解这一点可能是值得的。如果相关方,例如内部人员,在这些私营公司之一拥有利益,则应在年度报告中披露。私营公司也可能对公司具有战略性利益。
Next Steps:
下一步:
It's always worth thinking about the different groups who own shares in a company. But to understand Shinva Medical InstrumentLtd better, we need to consider many other factors. Take risks for example - Shinva Medical InstrumentLtd has 1 warning sign we think you should be aware of.
始终值得考虑有多个股份的公司的不同群体。但是要更好地了解新华医疗,我们需要考虑许多其他因素。以风险为例——新华医疗有一个我们认为您应该注意的风险警示指数。
Ultimately the future is most important. You can access this free report on analyst forecasts for the company.
最终,未来最重要。您可以在这份关于该公司分析师预测的免费报告中获取有关信息。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。